Organigram CEO Greg Engel steps down, Peter Amirault appointed on interim basis
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 03/05/2021 (1622 days ago), so information in it may no longer be current.
MONCTON, N.B. – Organigram Holdings Inc. says Greg Engel is stepping down from his chief executive post.
The Moncton, N.B.-based cannabis company did not offer details on Engel’s departure, but says he will continue to act as a special adviser to the board during a “transition period.
Organigram’s board chairman Peter Amirault has been appointed to serve as executive chair on an interim basis and oversee day-to-day management of the company until a new CEO is named.
Engel has led the company since 2017 and was recently involved with signing Organigram’s $221-million deal with British American Tobacco.
In the months leading up to the deal, Organigram announced it would cultivate less cannabis than its Moncton facilities were designed to produce.
It also laid off at least 220 workers, or roughly one-quarter of its staff.
This report by The Canadian Press was first published May 3, 2021.
Companies in this story: (TSX:OGI)